Bayard R Huck

This inventor holds 36 USPTO granted patents and 7 published patent applications, plus 16 CIPO patents and 18 EPO patents, primarily in Cancer Therapeutics. Top assignees: Merck Patent Gmbh, Athersys, Inc., Abt Holding Company. Active years: 2011-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bayard R Huck. Retrieved from https://idiyas.com/inventor/bayard-r-huck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 36 (Patent Applications = 7)

% Patents Active = 33.3

CIPO Patents = 16 (Patent Applications = 4)

EPO Patents = 18 (Patent Applications = 21)

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 48(Granted Patents)

Location History:

University Heights, OH (US) (2011)
Sudbury, MA (US) (2011 - 2022)

Company Filing History:

Years Active: 2011-2022

Loading Chart...

Areas of Expertise:

Cancer Treatment

Kinase Inhibitors

Heterocycles

Pyrimidine Compounds

Amino Derivatives

Protein Kinase

Tricyclic Compounds

Cyclic Amines

Imidazole Derivatives

Azaheterocycles

Pyrido Compounds

Serotonin Receptor Modulators

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11491153 - Methods for treating cancer using pyrimidine and pyridine compounds with BTK inhibitory activity (2022-11-08),

2. 10287300 - Heterocyclic derivatives as modulators of kinase activity (2019-05-14),

3. 10233160 - Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors (2019-03-19),

4. 10087166 - Cyclic amine azaheterocyclic carboxamides (2018-10-02),

5. 10080753 - Heterocyclic carboxamides as modulators of kinase activity (2018-09-25),

6. 10080750 - Aminopyrimidine derivatives for use as modulators of kinase activity (2018-09-25),

7. 9981925 - Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors (2018-05-29),

8. 9980966 - Combinations of cancer therapeutics (2018-05-29),

9. 9938268 - C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof (2018-04-10),

10. 9867826 - Heterocycles as modulators of kinase activity (2018-01-16),

11. 9850255 - Heterocyclic derivatives as modulators of kinase activity (2017-12-26),

12. 9662330 - Aminopyrimidine derivatives for use as modulators of kinase activity (2017-05-30),

13. 9586938 - Cyclic amine azaheterocyclic carboxamides (2017-03-07),

14. 9580443 - Heterocyclic derivatives as modulators of kinase activity (2017-02-28),

15. 9458134 - Heterocycles as modulators of kinase activity (2016-10-04),

Title: The Innovative Mind of Bayard R Huck

Introduction: Bayard R Huck, a distinguished inventor hailing from Sudbury, MA (US), is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Bayard R Huck's latest patents showcase his forward-thinking approach and commitment to pushing the boundaries of technological advancement. His recent inventions have garnered widespread acclaim for their ingenuity and practical applications.

Career Highlights: Throughout his illustrious career, Bayard R Huck has consistently demonstrated a keen ability to transform innovative ideas into tangible solutions. His work has not only revolutionized the industry but has also inspired a new generation of inventors to think outside the box.

Collaborations: Bayard R Huck has collaborated with some of the brightest minds in the industry, fostering a culture of creativity and collaboration that has led to numerous breakthroughs. His ability to work seamlessly in a team setting has been instrumental in the success of many projects.

Conclusion: In conclusion, Bayard R Huck's passion for innovation and relentless pursuit of excellence have solidified his reputation as a trailblazer in the world of technology. His contributions continue to shape the landscape of the industry, leaving an indelible mark on the future of innovation.

Profile summary based on public USPTO records.